-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LuSfdkZlGPw5f2OzNGfby41V2myvs+jDt2qLZBEtyE5vL/inBjts73JHWf/nJ4i/ u+c5ZI3nBijY8DC6GOTjPw== 0001193125-10-035450.txt : 20100222 0001193125-10-035450.hdr.sgml : 20100222 20100219215357 ACCESSION NUMBER: 0001193125-10-035450 CONFORMED SUBMISSION TYPE: 8-A12G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20100222 DATE AS OF CHANGE: 20100219 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NMT MEDICAL INC CENTRAL INDEX KEY: 0001017259 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 954090463 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-A12G/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-21001 FILM NUMBER: 10620975 BUSINESS ADDRESS: STREET 1: 27 WORMWOOD STREET CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6177370930 MAIL ADDRESS: STREET 1: 27 WORMWOOD STREET CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: NITINOL MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 19960619 8-A12G/A 1 d8a12ga.htm AMENDMENT NO.3 TO FORM 8-A Amendment No.3 to Form 8-A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-A/A

Amendment No. 3 to

Form 8-A

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

NMT Medical, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   95-4090463
(State of Incorporation or Organization)   (I.R.S. Employer Identification No.)

27 Wormwood Street

Boston, Massachusetts

  02210-1625
(Address of Principal Executive Offices)   (Zip Code)

 

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class

to be so registered

 

Name of each exchange on which

each class to be so registered

Common Stock (and associated Series A Junior Participating Preferred

Stock purchase rights), $.001 par value

  NASDAQ Capital Market

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box.  x

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box.  ¨

Securities Act registration statement file number to which this form relates (if applicable): Not applicable

Securities to be registered pursuant to Section 12(g) of the Act: None

 

 

 


Amendment No. 3 to Form 8-A

The undersigned Registrant hereby amends the following Items, exhibits or other portions of its Registration Statement on Form 8-A dated June 8, 1999, as amended by Amendment No. 1 dated December 15, 2006 and Amendment No. 2 dated June 9, 2009 as set forth in the pages attached hereto.

 

Item 1. Description of Registrant’s Securities to be Registered.

Item 1 of the Form 8-A dated June 8, 1999, as amended by Amendment No. 1 dated December 15, 2006 and Amendment No. 2 dated June 9, 2009 (the “Form 8-A”) filed by NMT Medical, Inc. (the “Company”) is hereby amended as follows:

On February 16, 2010, the Company entered into Amendment No. 3 (the “Amendment”) to the Rights Agreement dated as of June 7, 1999, and amended on December 14, 2006 and June 8, 2009 (as amended, the “Rights Agreement”), between the Company and American Stock Transfer & Trust Company, LLC (formerly American Stock Transfer & Trust Company), the Rights Agent. Capitalized terms used herein but not otherwise defined shall have the meanings ascribed to them in the Rights Agreement.

Pursuant to the Amendment, the definition of “Acquiring Person” in the Rights Agreement shall not include an “Exempted Person,” and an “Exempted Person” shall mean Glenhill Capital, LP and its Affiliates (as such term is defined in the Rights Agreement), unless and until such time as such Person, together with its Affiliates, directly or indirectly, becomes the Beneficial Owner of more than 25% of the Common Stock then outstanding, in which case such Person shall cease to be an Exempted Person.

The foregoing summary of the Amendment does not purport to be complete and is qualified in its entirety by reference to the Amendment, which is attached as Exhibit 3 hereto and incorporated herein by reference.

 

Item 2. Exhibits.

Item 2 of the Form 8-A is hereby amended by adding the following exhibit attached hereto:

 

Exhibit
No.

 

Description

4   Amendment No. 3, dated as of February 16, 2010, to Rights Agreement, dated as of June 7, 1999, between NMT Medical, Inc. and American Stock Transfer & Trust Company, LLC, as amended on December 14, 2006 and June 8, 2009.


SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this Amendment No. 3 to registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    NMT MEDICAL, INC.
Date: February 22, 2010     By:  

/s/    RICHARD E. DAVIS        

      Richard E. Davis
      Chief Operating Officer


EXHIBIT INDEX

 

Exhibit

No.

 

Description

4   Amendment No. 3, dated as of February 16, 2010, to Rights Agreement, dated as of June 17, 1999, between NMT Medical, Inc. and American Stock Transfer & Trust Company, LLC, as amended on December 14, 2006 and June 8, 2009.
EX-4 2 dex4.htm AMENDMENT NO.3 TO RIGHTS AGREEMENT Amendment No.3 to Rights Agreement

Exhibit 4

Execution Copy

AMENDMENT NO. 3 TO

RIGHTS AGREEMENT

This AMENDMENT, dated as of February 16, 2010 (the “Amendment”), amends the Rights Agreement, dated as of June 7, 1999, as amended on December 14, 2006 and further amended on June 8, 2009 (as amended to date, the “Rights Agreement”), between NMT Medical, Inc. (formerly Nitinol Medical Technologies, Inc.), a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, LLC, a New York limited liability company (formerly known as American Stock Transfer & Trust Company), as Rights Agent (the “Rights Agent”).

WHEREAS, under Section 27 of the Rights Agreement, the Company may from time to time supplement or amend the Rights Agreement without the approval of any holders of the Rights in order to, among other thing, make any provisions with respect to the Rights that the Company may deem necessary or desirable, any such supplement or amendment to be evidenced by a writing signed by the Company and the Rights Agent; and

WHEREAS, the Company has determined, and has so directed the Rights Agent, to amend the Rights Agreement as set forth herein pursuant to Section 27 of the Rights Agreement.

NOW, THEREFORE, in consideration of the foregoing and the mutual agreements set forth herein, and intending to be legally bound, the parties hereto agree as follows:

1. The first sentence of Section 1(a) is restated to read in its entirety as follows:

““Acquiring Person” shall mean any Person who or which, together with all Affiliates and Associates of such Person, shall be the Beneficial Owner of 15% or more of the shares of Common Stock then outstanding, but shall not include (i) the Company, (ii) any Subsidiary of the Company, (iii) any employee benefit plan of the Company or of any Subsidiary of the Company, (iv) any Person organized, appointed or established by the Company for or pursuant to the terms of any such plan, or (v) an Exempted Person.”

2. Section 1(m) is restated to read in its entirety as follows:

““Exempted Person” shall mean Glenhill Capital, LP, a Delaware Limited Liability Partnership, unless and until such time as such Person, together with its Affiliates, directly or indirectly, becomes the Beneficial Owner of more than 25% of the Common Stock then outstanding, in which case such Person shall cease to be an Exempted Person.”

3. This Amendment shall be deemed to be a contract made under the laws of the State of Delaware and for all purposes shall be governed by and construed in accordance with the laws of the State of Delaware applicable to contracts to be made and performed entirely within the State of Delaware.


4. All acts and things necessary to make this Amendment a valid agreement, enforceable according to its terms, have been done and performed, and the execution and delivery of this Amendment by the Company and the Rights Agent have been in all respects duly authorized by the Company and the Rights Agent.

5. This Amendment may be executed in any number of counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

6. In all respects not inconsistent with the terms and provisions of this Amendment, the Rights Agreement is hereby ratified, adopted, approved and confirmed. In executing and delivering this Amendment, the Rights Agent shall be entitled to all the privileges and immunities afforded to the Rights Agent under the terms and conditions of the Rights Agreement.

7. Capitalized terms used herein and not otherwise defined shall have the meanings given to such terms in the Rights Agreement.

[Remainder of page intentionally left blank]

 

- 2 -


IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and attested, as of the date first set forth above.

 

Attest:     NMT MEDICAL, INC.
By:  

/s/ Jill McClain

    By:  

/s/ Richard E. Davis

Name:   Jill McClain     Name:   Richard E. Davis
      Title:   CFO / COO / EVP
Attest:      

AMERICAN STOCK TRANSFER & TRUST

COMPANY, LLC

By:  

 

    By:  

/s/ Herbert J. Lemmer

Name:  

 

    Name:   Herbert J. Lemmer
Title:  

 

    Title:   Vice President
-----END PRIVACY-ENHANCED MESSAGE-----